Cargando…

Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data

Idiopathic non-cirrhotic portal hypertension (INCPH) is a clinicopathologic disease entity characterized by the presence of clinical signs and symptoms of portal hypertension (PH) in the absence of liver cirrhosis or known risk factors accountable for PH. Multiple hematologic, immune-related, infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kmeid, Michel, Liu, Xiuli, Ballentine, Samuel, Lee, Hwajeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110235/ https://www.ncbi.nlm.nih.gov/pubmed/34007347 http://dx.doi.org/10.14740/gr1376

Ejemplares similares

Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease
por: Nicoară-Farcău, Oana, et al.
Publicado: (2020)

Interobserver study on histologic features of idiopathic non-cirrhotic portal hypertension
por: Kmeid, Michel, et al.
Publicado: (2020)

Histologic Lesions of Porto-Sinusoidal Vascular Disease Following Phlebotomy in Hemochromatosis
por: El Jabbour, Tony, et al.
Publicado: (2020)

Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis?
por: Gioia, Stefania, et al.
Publicado: (2019)

Porto-Sinusoidal Vascular Disease as the Cause of Portal Hypertension in Felty's Syndrome: A Case Report and Literature Review
por: Yang, Song, et al.
Publicado: (2020)

Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder
por: Lampichler, Katharina, et al.
Publicado: (2022)

Idiopathic non-cirrhotic portal hypertension: a review
por: Schouten, Jeoffrey NL, et al.
Publicado: (2015)

Portal vein thrombosis leading to pre-sinusoidal non-cirrhotic portal hypertension resulting in decreased synthetic function of the liver
por: Kline, Kevin, et al.
Publicado: (2019)

Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It
por: Puente, Angela, et al.
Publicado: (2019)

Idiopathic Noncirrhotic Portal Hypertension: An Appraisal
por: Lee, Hwajeong, et al.
Publicado: (2016)

Porto-Sinusoidal Vascular Disease in a Patient With Diffuse Aortitis and Massive Ascites
por: Lin, Emily, et al.
Publicado: (2022)

Progressive dyspnoea in a patient with idiopathic non-cirrhotic portal hypertension
por: Cullivan, Sarah, et al.
Publicado: (2022)

Carvedilol Ameliorates Intrahepatic Angiogenesis, Sinusoidal Remodeling and Portal Pressure in Cirrhotic Rats
por: Ling, Liping, et al.
Publicado: (2018)

Spontaneous porto‐femoral shunting in long‐standing portal hypertension
por: Giuffrè, Mauro, et al.
Publicado: (2020)

Idiopathic Non Cirrhotic Portal Hypertension and Spleno-Portal Axis Abnormalities in Patients with Severe Primary Antibody Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2014)

Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension
por: Klein, Sabine, et al.
Publicado: (2016)

Genetic predisposition to porto‐sinusoidal vascular disorder: A functional genomic‐based, multigenerational family study
por: Shan, Jingxuan, et al.
Publicado: (2023)

Causes and Management of Non-cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2020)

Porto-Sinusoidal Vascular Disease: A Concise Updated Summary of Epidemiology, Pathophysiology, Imaging, Clinical Features, and Treatments
por: Jin, Su Jin, et al.
Publicado: (2023)

Non-cirrhotic portal hypertension in an ankylosing spondylitis patient
por: Park, Sukki, et al.
Publicado: (2018)

Non-Cirrhotic Portal Hypertension in Systemic Lupus Erythematosus
por: Suárez-Díaz, Silvia, et al.
Publicado: (2023)

Laparoscopic splenectomy and porto-azygos disconnection: clinical research in the treatment of portal hypertension
por: Fengyong, Wang, et al.
Publicado: (2015)

Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
por: Uschner, Frank E., et al.
Publicado: (2015)

Idiopathic non-cirrhotic portal hypertension in a patient with Talaromyces marneffei infection: a case report
por: Ye, Xiuling, et al.
Publicado: (2023)

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension
por: Biecker, Erwin
Publicado: (2013)

Contrast‐enhanced CT and liver surface nodularity for the diagnosis of porto‐sinusoidal vascular disorder: A case‐control study
por: Valainathan, Shantha Ram, et al.
Publicado: (2022)

Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension: a case report: Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension
por: Abou Yassine, Ahmad, et al.
Publicado: (2023)

Wall shear stress in portal vein of cirrhotic patients with portal hypertension
por: Wei, Wei, et al.
Publicado: (2017)

The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension
por: Saeki, Michio, et al.
Publicado: (2023)

Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension
por: MUTI, LEON ADRIAN, et al.
Publicado: (2015)

Chronic Myeloid Leukemia Presenting as Non-cirrhotic Portal Hypertension
por: Gemnani, Rinkle R, et al.
Publicado: (2023)

Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: Its relevance in the management of portal hypertension
por: Gupta, Shahana, et al.
Publicado: (2020)

Idiopathic noncirrhotic portal hypertension: current perspectives
por: Riggio, Oliviero, et al.
Publicado: (2016)

Gastric Varices in Absence of Splenic Vein Thrombosis: A Rare Entity of Idiopathic Non-Cirrhotic Portal Hypertension
por: Choksi, Vivek, et al.
Publicado: (2017)

A Case of Idiopathic Non-Cirrhotic Portal Hypertension in a Patient With a Left Ventricular Assist Device
por: Kothari, Shana, et al.
Publicado: (2019)

Cardiac dysfunction in cirrhotic portal hypertension with or without ascites
por: Dadhich, Sunil, et al.
Publicado: (2014)

The beneficial effects of curcumin in cirrhotic rats with portal hypertension
por: Hsu, Shao-Jung, et al.
Publicado: (2017)

Research progress on signaling pathways in cirrhotic portal hypertension
por: Xu, Wen, et al.
Publicado: (2018)

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
por: Gunarathne, Lakmie S, et al.
Publicado: (2020)

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension
por: Ørntoft, Nikolaj Worm, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p8vkbscv0f5d0345se7otqgj6f